These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17983827)

  • 1. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 2. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract]   [Full Text] [Related]  

  • 3. Flawed Australian CD study does not end MAP controversy.
    Lipton JE; Barash DP
    Gastroenterology; 2007 Nov; 133(5):1742; author reply 1745-6. PubMed ID: 17983825
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L; Biesecker J
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract]   [Full Text] [Related]  

  • 5. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
    Hermon-Taylor J
    Dig Liver Dis; 2002 Jan; 34(1):9-12. PubMed ID: 11926580
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimycobacterial therapy in Crohn's disease: game over?
    Peyrin-Biroulet L; Neut C; Colombel JF
    Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease].
    Ormaechea JI; Gisbert JP; Marín-Jiménez I
    Gastroenterol Hepatol; 2009 May; 32(5):353-63. PubMed ID: 19457586
    [No Abstract]   [Full Text] [Related]  

  • 10. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
    Hermon-Taylor J
    Gut; 2001 Dec; 49(6):755-6. PubMed ID: 11709506
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis.
    Chamberlin W; Ghobrial G; Chehtane M; Naser SA
    Am J Gastroenterol; 2007 Mar; 102(3):689-91. PubMed ID: 17335456
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
    Savarino E; Bertani L; Ceccarelli L; Bodini G; Zingone F; Buda A; Facchin S; Lorenzon G; Marchi S; Marabotto E; De Bortoli N; Savarino V; Costa F; Blandizzi C
    Expert Opin Biol Ther; 2019 Feb; 19(2):79-88. PubMed ID: 30574820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evidence for Mycobacterium paratuberculosis in Crohn's disease.
    Behr MA; Kapur V
    Curr Opin Gastroenterol; 2008 Jan; 24(1):17-21. PubMed ID: 18043227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causation of Crohn's disease and treatment with antimicrobial drugs.
    Hermon-Taylor J
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):607-10. PubMed ID: 10076782
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution of Crohn's (Johne's) disease with antibiotics: what are the next steps?
    Davis WC; Kuenstner JT; Singh SV
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):393-396. PubMed ID: 28276276
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of antimycobacterial agents in Crohn's disease.
    Thayer WR
    J Clin Gastroenterol; 1992 Jul; 15(1):5-7. PubMed ID: 1323594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease.
    Hermon-Taylor J; Barnes N; Clarke C; Finlayson C
    BMJ; 1998 Feb; 316(7129):449-53. PubMed ID: 9492675
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Borody TJ; Bilkey S; Wettstein AR; Leis S; Pang G; Tye S
    Dig Liver Dis; 2007 May; 39(5):438-44. PubMed ID: 17369114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveitis in a patient receiving rifabutin for Crohn's disease.
    Awotesu O; Missotten T; Pitcher MC; Lynn WA; Lightman S
    J R Soc Med; 2004 Sep; 97(9):440-1. PubMed ID: 15340029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.